Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed)
Track This Opportunity
Create an account to track opportunities.
About This Opportunity
This is a grant from the National Institutes of Health (NIH) aimed at supporting projects that accelerate the development of innovative products for clinical adoption. It's designed for researchers and organizations working on healthcare solutions, specifically excluding funding for clinical trials, to help bring promising technologies closer to patient care.
Eligibility Requirements
Application Guide
Selection will likely be based on the scientific merit, innovation, potential for clinical impact, and feasibility of the proposed product development activities, ensuring they do not involve clinical trials.
Founders should clearly articulate the innovative aspects of their product and its pathway to clinical adoption. Emphasize how the project accelerates product excellence without engaging in clinical trial activities, aligning with the 'Clinical Trial Not Allowed' stipulation.
Geographic Coverage
Links & Resources
Source & freshness
Last verified: 6/16/2026
Primary source: Official source page
Refresh cadence: Listings are refreshed weekly.
Reminder: Confirm eligibility and deadlines before applying.